This site is intended for health professionals only

Published on 6 July 2007

Share this story:

RELATED ARTICLES
Join us for new Clinical Excellence in Respiratory Care event
Dismayed reactions from sector over proposed GPhC fees increase
Dapagliflozin use in heart failure extended by NICE to reduce hospitalisations
Study confirms spironolactone safe and effective for treating acne in women
Calls for HCPs to respond to major conditions strategy consultation

Rosuvastatin freed from black triangle

teaser

Following a comprehensive analysis of pre- and postmarketing data by the UK’s MHRA and Commission on Human Medicines, the risk-benefit profile for rosuvastatin (Crestor



Most read

1
Oral vitamin A could become an alternative to isotretinoin for acne
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Praise for tighter decongestant controls
Personalising peptide vaccines for treating glioblastoma: expert pharmacist commentary
Drug “bubbles” to fight cancer
Neupro filed with FDA for restless legs syndrome
CHMP positive opinion for Xultophy?
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x